Ewout W. Steyerberg

Leiden University Medical Center, Erasmus University Rotterdam

Papers

2

Total Citations

346

H-Index

2

About

Ewout W. Steyerberg is a leading biostatistician and clinical prediction modeler whose work has transformed surgical decision-making and risk assessment. His research focuses on developing and validating prognostic models that improve patient outcomes, particularly in pancreatic and prostate cancer surgery. Steyerberg’s major contributions include the creation of the updated Alternative Fistula Risk Score (ua-FRS), a validated tool that predicts postoperative pancreatic fistula risk after minimally invasive pancreatoduodenectomy. This model, cited over 195 times, helps surgeons tailor operative approaches to individual patient risk. He also led a landmark multinational study comparing positive surgical margin rates across 22,393 patients undergoing open, laparoscopic, and robot-assisted radical prostatectomy, cited 151 times, which provided critical evidence on surgical technique outcomes. Steyerberg’s work is characterized by rigorous methodology and large-scale data synthesis, earning him recognition as a pioneer in clinical prediction modeling. His research has been instrumental in advancing personalized surgery, reducing complications, and setting standards for evidence-based practice in high-risk procedures.

Research Focus

Key Achievements

2
H-Index
2
Papers
346
Total Citations
173
Avg Citations/Paper
🏆 Most Cited Paper
Updated Alternative Fistula Risk Score (ua-FRS) to Include Minimally Invasive Pancreatoduodenectomy
195 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 44
🏛 Institutions: Leiden University Medical Center, Erasmus University Rotterdam

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago